Updated: January 17, 2026
Alternatives to Synarel If You Can't Fill Your Prescription
Author
Peter Daggett

Summarize with AI
- How Synarel Works — And Why That Matters for Alternatives
- Alternative #1: Leuprolide (Lupron Depot, Eligard, Fensolvi)
- Alternative #2: Goserelin (Zoladex)
- Alternative #3: Elagolix (Orilissa) — For Endometriosis Only
- Alternatives for Central Precocious Puberty (CPP)
- Important: Don't Switch Without Your Doctor's Guidance
If your pharmacy doesn't have Synarel in stock, there are GnRH agonist alternatives your doctor may be able to prescribe. Here's what to know before switching.
Synarel (nafarelin acetate) is a brand-only nasal spray with no generic equivalent in the United States, making it one of the harder GnRH medications to find at a pharmacy. If you're facing a supply gap or can't afford the $3,100–$3,500 cash price, you may be wondering: are there alternatives?
The good news: yes. Several other medications work through the same or similar mechanisms and are FDA-approved for the same conditions. However, no two GnRH medications are identical — dosing, route, and insurance coverage all differ. Always consult your doctor before making any changes.
How Synarel Works — And Why That Matters for Alternatives
Synarel is a GnRH agonist. It works by initially stimulating GnRH receptors in the pituitary gland, causing a brief surge in LH and FSH, followed by receptor desensitization. After about 4 weeks of twice-daily use, the pituitary stops responding, and estrogen (and testosterone) levels drop significantly — by up to 95%.
This hormone suppression is what makes GnRH agonists effective for endometriosis (shrinks estrogen-dependent tissue) and central precocious puberty (halts premature hormonal development). Alternatives to Synarel generally fall into two categories: other GnRH agonists and GnRH antagonists.
Alternative #1: Leuprolide (Lupron Depot, Eligard, Fensolvi)
Leuprolide is the most widely used GnRH agonist in the United States. It's available as a monthly injection (Lupron Depot 3.75 mg for endometriosis, 7.5 mg for other uses) or 3-month depot formulation. For central precocious puberty, Lupron Depot-PED is available in several doses.
Key comparison vs. Synarel:
Route: Intramuscular injection vs. nasal spray
Frequency: Monthly or every 3 months vs. twice daily nasal spray
Availability: More widely stocked but has faced intermittent shortages
Approvals: FDA-approved for endometriosis, CPP, uterine fibroids, and prostate cancer
Alternative #2: Goserelin (Zoladex)
Goserelin is a GnRH agonist delivered as a small subcutaneous implant injected into the abdominal wall — monthly (3.6 mg) or every 3 months (10.8 mg). It's FDA-approved for endometriosis and prostate/breast cancer.
Key comparison vs. Synarel:
Monthly or 3-month subcutaneous implant vs. daily nasal spray
No FDA approval for CPP — leuprolide or triptorelin are preferred for children
Generally better stocked at oncology clinics and gynecology offices
Alternative #3: Elagolix (Orilissa) — For Endometriosis Only
Elagolix (brand name Orilissa) is an oral GnRH antagonist — a different mechanism than Synarel, but the same end result: lower estrogen. Unlike GnRH agonists (which cause an initial flare), GnRH antagonists suppress hormones immediately without the initial surge.
Key comparison vs. Synarel for endometriosis:
Route: Daily oral pill vs. twice-daily nasal spray
Mechanism: GnRH antagonist (no initial hormone flare) vs. GnRH agonist
Only for endometriosis — not approved for CPP
Alternatives for Central Precocious Puberty (CPP)
For children with CPP, there are several FDA-approved GnRH agonist alternatives to Synarel:
Triptorelin (Triptodur): A 6-month intramuscular injection for CPP, reducing dosing burden significantly
Histrelin (Supprelin LA): A subcutaneous implant placed in the upper arm that lasts 12 months — the longest-acting option for CPP
Leuprolide depot (Lupron Depot-PED): Monthly or 3-month injection, the most widely used CPP treatment in the US
Important: Don't Switch Without Your Doctor's Guidance
GnRH medications are not interchangeable without medical supervision. Doses, administration routes, and monitoring requirements vary considerably. Your doctor needs to consider:
Your specific condition (endometriosis vs. CPP vs. other)
How far into your treatment course you are
Insurance authorization requirements for the alternative
Your preference for injection vs. nasal spray vs. oral
Before giving up on Synarel entirely, try using medfinder to locate a pharmacy that currently has it in stock. medfinder calls pharmacies near you to find which ones can fill your prescription — saving you hours of calls.
For current availability information, see our Synarel shortage update for 2026.
Frequently Asked Questions
Leuprolide (Lupron Depot) and goserelin (Zoladex) are the most commonly used GnRH agonist alternatives to Synarel for endometriosis. Elagolix (Orilissa) is an oral GnRH antagonist option. The best alternative depends on your specific treatment history, insurance, and preference for route of administration. Your OB/GYN or reproductive endocrinologist can help you decide.
For CPP, leuprolide depot (Lupron Depot-PED) is the most widely used alternative — available as a monthly or 3-month injection. Triptorelin (Triptodur) is a 6-month injection option, and histrelin (Supprelin LA) is a 12-month subcutaneous implant. A pediatric endocrinologist should guide any transition.
Both Synarel and leuprolide (Lupron Depot) are GnRH agonists and are clinically comparable for endometriosis. The main differences are the route (nasal spray vs. injection) and dosing frequency (twice daily vs. monthly). Neither has been shown to be clearly superior in head-to-head trials. Many patients prefer the convenience of a monthly injection over a twice-daily nasal spray.
Switching GnRH agonists mid-treatment is possible but requires careful coordination with your doctor. The prescriber needs to determine the appropriate transition dose and timing to avoid gaps in hormone suppression. Never make this switch on your own — always work with your prescribing physician.
Yes — elagolix (Orilissa) is an oral GnRH antagonist approved for moderate-to-severe endometriosis. Unlike Synarel (a nasal spray GnRH agonist), elagolix is taken as a daily pill and works by a slightly different mechanism. However, Orilissa is not approved for CPP and may not be appropriate for all patients. Discuss with your doctor.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Synarel also looked for:
More about Synarel
33,257 have already found their meds with Medfinder.
Start your search today.





